ABL Diagnostics Confirms BSI Partnership for a Seamless IVDR Transition, Securing Long-Term Availability of its CE-IVD Medical Devices

Boursorama Bourse - 16/07
Woippy, July 16, 2026 – ABL Diagnostics (Euronext Paris: ABLD), a leader in molecular diagnostics for infectious diseases, announced a major milestone in its transition to the European IVDR (EU) 2017/746. In coordination with its parent company, the legal manufacturer

Woippy, July 16, 2026 – ABL Diagnostics (Euronext Paris: ABLD), a leader in molecular diagnostics for infectious diseases, announced a m...
[Courte citation de 8% de l'article original]

Loading...